A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira vaccine in Healthy 'Adults' aged greater than or equal to 18 to less than 60 years and in Healthy 'Older Adults' aged greater than or equal to 60 years for the 2008/2009 Northern Hemisphere Influenza Season

Trial Profile

A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira vaccine in Healthy 'Adults' aged greater than or equal to 18 to less than 60 years and in Healthy 'Older Adults' aged greater than or equal to 60 years for the 2008/2009 Northern Hemisphere Influenza Season

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 May 2012

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top